RecruitingNCT04308564

Laboratory and Clinical Data in Antiphospholipid Patients

Constitution d'Une Collection d'Echantillons Biologiques Associee a Une Base de Donnees de Patients Possedant Des Anticorps Antiphospholipides

Sponsor

Central Hospital, Nancy, France

Enrollment

60 participants

Start Date

Apr 12, 2021

Study Type

OBSERVATIONAL

Conditions

Antiphospholipid Syndrome

Summary

To constitute a registry of antiphospholipid antibodies positive-patients

Eligibility

Min Age: 18 Years

Inclusion Criteria2

age between 18 and 60 years;
persistent (at least 12 weeks apart) aPL-positivity within 12 months prior to screening

Exclusion Criteria3

no inform consent
impossible follow up
pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood test

Blood test for the identification of biomarkers

Locations(2)

CHRU de Lille

Lille, France

CHRU de Nancy

Nancy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04308564

Related Trials

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

NCT0019806810 locations

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

NCT070879122 locations